Evotec Se Stock Performance

EVOTF Stock  USD 13.83  0.00  0.00%   
The firm shows a Beta (market volatility) of -2.64, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Evotec SE are expected to decrease by larger amounts. On the other hand, during market turmoil, Evotec SE is expected to outperform it. Evotec SE has an expected return of -0.84%. Please make sure to confirm Evotec SE variance and skewness , to decide if Evotec SE performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Evotec SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow422.6 M
Total Cashflows From Investing Activities-243.9 M
  

Evotec SE Relative Risk vs. Return Landscape

If you would invest  2,461  in Evotec SE on December 29, 2023 and sell it today you would lose (1,078) from holding Evotec SE or give up 43.8% of portfolio value over 90 days. Evotec SE is currently producing negative expected returns and takes up 3.8398% volatility of returns over 90 trading days. Put another way, 33% of traded pink sheets are less volatile than Evotec, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Evotec SE is expected to under-perform the market. In addition to that, the company is 6.7 times more volatile than its market benchmark. It trades about -0.22 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.23 per unit of volatility.

Evotec SE Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Evotec SE's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Evotec SE, and traders can use it to determine the average amount a Evotec SE's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2187

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsEVOTF

Estimated Market Risk

 3.84
  actual daily
33
67% of assets are more volatile

Expected Return

 -0.84
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.22
  actual daily
0
Most of other assets perform better
Based on monthly moving average Evotec SE is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evotec SE by adding Evotec SE to a well-diversified portfolio.

Evotec SE Fundamentals Growth

Evotec Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Evotec SE, and Evotec SE fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evotec Pink Sheet performance.

About Evotec SE Performance

To evaluate Evotec SE Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Evotec SE generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Evotec Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Evotec SE market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Evotec's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. EVOTEC SE operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4521 people.

Things to note about Evotec SE performance evaluation

Checking the ongoing alerts about Evotec SE for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Evotec SE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evotec SE generated a negative expected return over the last 90 days
Evotec SE has high historical volatility and very poor performance
About 66.0% of the company shares are held by institutions such as insurance companies
Evaluating Evotec SE's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Evotec SE's pink sheet performance include:
  • Analyzing Evotec SE's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evotec SE's stock is overvalued or undervalued compared to its peers.
  • Examining Evotec SE's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Evotec SE's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evotec SE's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Evotec SE's pink sheet. These opinions can provide insight into Evotec SE's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Evotec SE's pink sheet performance is not an exact science, and many factors can impact Evotec SE's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Evotec Pink Sheet analysis

When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.